These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4409491)

  • 21. [Acute hepatitis caused by erythromycin propionate].
    Ponsot P; Théodore C; Larrey D; Breil P; Hugentobler JP; Paolaggi JA
    Gastroenterol Clin Biol; 1982; 6(6-7):594. PubMed ID: 7117770
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cholestasis hepatitis caused by erythromycin propionate].
    Ortuño JA; Olaso V; Berenguer J
    Med Clin (Barc); 1984 May; 82(20):912. PubMed ID: 6748800
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cholestatic hepatitis caused by erythromycin propionate].
    de Escalante B; Sampedro JA; Zabala S; Gracia P
    An Med Interna; 1990 Dec; 7(12):656. PubMed ID: 2135589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Crossed hepatotoxicity of erythromycin propionate and troleandomycin?].
    Luherne JY; Pariente EA; Maitre F
    Gastroenterol Clin Biol; 1988 Nov; 12(11):869-70. PubMed ID: 3265396
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatotoxicity of erythromycin derivatives.
    Pessayre D; Benhamou JP
    Br Med J; 1979 May; 1(6174):1357. PubMed ID: 445081
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythromycin-induced hepatitis: simulator of malignancy.
    Rigauts HD; Selleslag DL; Van Eyken PL; Van Damme BJ; Fevery JM; Marchal GJ
    Radiology; 1988 Dec; 169(3):661-2. PubMed ID: 3055031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controlled study of the liver-protective effect of cycloxilic acid in a form of iatrogenic liver disease].
    Neuman M; Fluteau G
    Clin Ter; 1978 Nov; 87(3):243-64. PubMed ID: 380876
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962.
    Gilbert FI
    Hawaii Med J; 1995 Jun; 54(6):603-5. PubMed ID: 7642362
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatic involvement induced by erythromycin propionate].
    Simon C; Roul G; Chabrier G; Schlienger JL; Imler M
    Rev Med Interne; 1985 Jan; 6(1):84-5. PubMed ID: 4001646
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatotoxicity: pathogenesis and therapeutic intervention.
    Black M
    Clin Gastroenterol; 1979 Jan; 8(1):89-104. PubMed ID: 369749
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis caused by drugs. 5].
    Valerdiz Casasola S; Linares Rodríguez A; Recarte Alvarez J; Rodrigo Sáez L
    Rev Esp Enferm Apar Dig; 1982 Nov; 62(5):431-44. PubMed ID: 6762631
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines.
    Carson JL; Strom BL; Duff A; Gupta A; Shaw M; Lundin FE; Das K
    Ann Intern Med; 1993 Oct; 119(7 Pt 1):576-83. PubMed ID: 8363168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfusion of the isolated rat liver with erythromycin estolate and other derivatives.
    Kendler J; Anuras S; Laborda O; Zimmerman HJ
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1272-5. PubMed ID: 5023324
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatotoxicity from erythromycin estolate].
    Saiz Santos S; Montero López L
    Aten Primaria; 1992 Dec; 10(9):1050. PubMed ID: 1467424
    [No Abstract]   [Full Text] [Related]  

  • 35. [Erythromycin].
    Dölle W
    Dtsch Med Wochenschr; 1979 Sep; 104(38):1330. PubMed ID: 477558
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible mild reaction to erythromycin ethyl succinate.
    Bena JH
    J Kans Med Soc; 1979 Jul; 80(7):418. PubMed ID: 458220
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute hepatitis caused by erythromycin].
    Rodríguez Cuartero A; Rodríguez Cuartero F; Alonso Fernández J; Castillo Higueras PL
    Rev Esp Enferm Apar Dig; 1978 Nov; 54(5):533-6. PubMed ID: 746229
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the article of J. Buchanec and V. Kdrajnák: Lesions of the liver during therapy with erythromycin in 3 children].
    Rouzica M; Filipová K
    Cesk Pediatr; 1975 Jan; 30(1-2):71. PubMed ID: 1132045
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotic toxicity.
    Johnson AH
    J S C Med Assoc; 1971 Aug; 67(8):351-2. PubMed ID: 5286588
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatotoxicity of erythromycin].
    García Buey L; García-Samaniego Rey J; González Estecha A; Pajares García JM
    Rev Clin Esp; 1989 Feb; 184(3):158. PubMed ID: 2785700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.